T Cell News and Research

Latest T Cell News and Research

Exposure to flame retardant impacts paternal reproduction

A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.

9 Jun 2020

Happiness could offer protection from gastrointestinal distress

Serotonin, a chemical known for its role in producing feelings of well-being and happiness in the brain, can reduce the ability of some intestinal pathogens to cause deadly infections, new research by UT Southwestern scientists suggests.

9 Jun 2020

Re-trafficking proteins to defend against Salmonella infections

When humans get infected by pathogenic bacteria, the body's immune system tries to eliminate the intruders.

9 Jun 2020

Research shows potential new therapeutic strategy for slowing down Huntington's disease

Scientists have described a potential new therapeutic strategy for slowing down early-stage Huntington's disease in a new study published today in eLife.

9 Jun 2020

Immune cell discovery could help develop new treatments for hepatitis B

For the first time, researchers at The Westmead Institute for Medical Research have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) infection. The discovery could help develop new treatments for HBV and inform future vaccine design.

9 Jun 2020

Study reveals new strategy to tackle cancer

A study led by the Institut de Neurociències describes a new strategy to tackle cancer, based on inducing a potent stress in tumor causing cell destruction by autophagy.

9 Jun 2020

New technique to identify genes implicated in the development of malignant brain tumor

Researchers at Uppsala University have developed a method for identifying functional mutations and their effect on genes relevant to the development of glioblastoma - a malignant brain tumor with a very poor prognosis. The study is published in Genome Biology.

9 Jun 2020

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.

From Santen Pharmaceutical Co., Ltd. 9 Jun 2020

New machine learning approach classifies common type of brain tumor

A new machine learning approach classifies a common type of brain tumor into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access.

9 Jun 2020

Halogenated flame retardant pose health risks to children

Harmful flame retardants may be lurking on your hands and cell phone, according to a peer-reviewed study published today in Environmental Science & Technology Letters.

9 Jun 2020

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

A new study published on the preprint server bioRxiv* in June 2020 reports the discovery of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in samples from healthy donors, collected before the pandemic. These antibodies are capable of inhibiting the binding of the spike protein of the virus to the angiotensin-converting enzyme 2 (ACE2) molecule and can neutralize active infection of cells in culture.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

A new study published on the preprint server medRxiv in June 2020 reports that one mechanism for this variable severity is the differential expression of the ACE2 receptor in various metabolic conditions, thereby facilitating viral entry into the host cells.

9 Jun 2020

New study shows possible alternative pathway of SARS-CoV-2 infection in overactive bladder

A new study published on the preprint server bioRxiv*, in June 2020, reports that the condition of overactive bladder (OAB) could be associated with a different route of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19 disease.

8 Jun 2020

Scientists harness cancer immunotherapy tools to identify targets for COVID-19 vaccine

Cancer researchers at Children's Hospital of Philadelphia have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus.

8 Jun 2020

New Canadian study investigates how cancer adapts its metabolism to overcome therapies

Knowing what cancer will do next could lessen the likelihood of it becoming resistant to treatment. A new Canadian study investigates how cancer adapts its metabolism to potentially overcome therapies still in development.

8 Jun 2020

Old antibiotic may be a powerful new tool against deadly superbug

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body.

8 Jun 2020

Chemotherapy and cancer join together to cause neuropathy

Contrary to common medical guidance, chemotherapy does not appear to be the only culprit in neuropathy, a neurological side effect of cancer treatment, a new study says. Cancer itself contributes heavily, too, and the stresses on neurons appear far worse than the sum of the two causes.

8 Jun 2020

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).

8 Jun 2020

SARS-CoV-2 infection causes specific kidney proximal tubular injury

SARS-CoV-2-associated acute kidney injury (AKI) is one of the more frequently encountered organ involvements in COVID-19 - in as many as 80% of critically ill patients, according to a recent study.

8 Jun 2020

T Cell News and Research

Latest T Cell News and Research

Exposure to flame retardant impacts paternal reproduction

Happiness could offer protection from gastrointestinal distress

Re-trafficking proteins to defend against Salmonella infections

Research shows potential new therapeutic strategy for slowing down Huntington's disease

Immune cell discovery could help develop new treatments for hepatitis B

Study reveals new strategy to tackle cancer

New technique to identify genes implicated in the development of malignant brain tumor

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

New machine learning approach classifies common type of brain tumor

Halogenated flame retardant pose health risks to children

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

COVID-19 produces lung inflammation in non-human primate experiments

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

New study shows possible alternative pathway of SARS-CoV-2 infection in overactive bladder

Scientists harness cancer immunotherapy tools to identify targets for COVID-19 vaccine

New Canadian study investigates how cancer adapts its metabolism to overcome therapies

Old antibiotic may be a powerful new tool against deadly superbug

Chemotherapy and cancer join together to cause neuropathy

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

SARS-CoV-2 infection causes specific kidney proximal tubular injury

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in